Review top news and interview highlights from the week ending December 22, 2023.
Welcome to CGTLive™’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.
The company has released positive safety data from the first 3 participants with HIV-1 so far, with no evidence of vector shedding in sexual organ tissue.
The professor of hematology at University of Lille and chair of LYSA also discussed what the group will be focusing on in 2024.
Rabi Hanna, MD, presented updated data from the RUBY and EdiThal trials at ASH 2023.
The postdoctoral researcher at Laboratory for Translational Cancer Immunology, Ludwig-Maximilians-Universität München, discussed the need for research into how CAR T-cells act differently between sexes.
Akshay Sharma, MBBS, a bone marrow transplant physician at St. Jude Children’s Research Hospital, also gave his thoughts on the recent FDA approval of Vertex and CRISPR’s exa-cel for sickle cell disease.